Novo Nordisk stock (NVO) jumped more than 2% in trading Wednesday after beating Wall Street's profit estimates for the first quarter and despite a slight cut to its sales forecast for the year.

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15 ... it would become the first GLP-1 oral drug for weight loss to hit the market. While Novo Nordisk ...

Some of the potential iterations of delivery methods Eli Lilly considered for orforglipron, at Eli Lilly’s headquarters in ... to hit the market. While Novo Nordisk currently makes an oral ...

Each building was distinctly designed, has a monorail going around a beautiful lawn campus. By the way, I’ve been to Huawei’s headquarters ... The fact that Novo Nordisk has created an ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis ... drug for weight loss to hit the market. While Novo Nordisk currently makes an oral GLP-1 drug, it’s only ...

Each building was distinctly designed, has a monorail going around a beautiful lawn campus. By the way, I’ve been to Huawei’s headquarters ... The fact that Novo Nordisk has created an ...

Chinese exports show the impact of U.S trade war, Meta’s stand-alone AI app will compete with rivals, and more news to start ...